{
  "paper_metadata": {
    "pmid": "37550352",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR Val30Met variant in the context of hereditary transthyretin amyloidosis, focusing on surgical outcomes and penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 20,
        "demographics": "Mean age 51.0 \u00b1 8.7 years, 12 males (60%), 8 females (40%)",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRv) with secondary glaucoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 20,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The TTR Val30Met variant is associated with hereditary transthyretin amyloidosis, leading to ocular manifestations including secondary glaucoma.",
        "assays": []
      },
      "segregation_data": "The variant is known to segregate with disease in families affected by ATTRv amyloidosis.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Introduction, paragraph 2",
      "additional_notes": "The study included patients with the TTR Val30Met variant only.",
      "key_quotes": [
        "Valine to methionine conversion at amino acid 30 (Val30Met) is the most common and well-studied among more than one hundred TTR variants."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The paper primarily discusses the TTR Val30Met variant and its implications in ATTRv amyloidosis."
  }
}